Paul Choi

Dec 19, 2025

Target

$95.00

Current

$51.22

Performance

0.00%

Paul Choi rated VERA as Buy on Dec 19, 2025, setting a price target of 95. Shares have remained stable near 51.22, leaving the 95 target still in play.

CYTK

Dec 19, 2025

Target

$95.00

Current

$62.72

Performance

0.00%

On Dec 19, 2025, CYTK was given a Buy rating by Paul Choi, with a target price of 95. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

PTCT

Nov 05, 2025

Target

$50.00

Current

$78.57

Performance

9.47%

PTCT received a Sell rating from Paul Choi on Nov 05, 2025, aiming for 50. Shares declined 9.47%, matching the cautious outlook.

BBIO

Oct 31, 2025

Target

$100.00

Current

$76.30

Performance

21.81%

On Oct 31, 2025, Paul Choi published a Buy outlook on BBIO, with a target of 100. Shares gained 21.81%, underscoring the accuracy of the bullish outlook toward 100.

KNSA

Oct 29, 2025

Target

$55.00

Current

$43.19

Performance

15.54%

Paul Choi on Oct 29, 2025 assigned KNSA a Buy rating, with a price target of 55. The Buy call aligned well with market performance, producing a gain of 15.54%.

ARVN

Oct 15, 2025

Target

$6.00

Current

$11.68

Performance

23.47%

On Oct 15, 2025, Paul Choi reaffirmed ARVN with a Sell rating, targeting 6. The Sell recommendation anticipated weakness, as shares dropped 23.47%.

LNTH

Oct 08, 2025

Target

$77.00

Current

$65.92

Performance

23.10%

LNTH was rated Neutral by Paul Choi on Oct 08, 2025, with a price objective of 77. Despite caution, upside momentum rewarded risk-takers with gains to 65.92.

EWTX

Sep 25, 2025

Target

$20.00

Current

$25.55

Performance

71.59%

On Sep 25, 2025, Paul Choi initiated coverage on EWTX with a Neutral rating and target of 20. The Hold stance underestimated the stock’s strength as it gained 71.59%.

EXEL

Sep 17, 2025

Target

$47.00

Current

$44.30

Performance

9.55%

Paul Choi issued a Buy recommendation for EXEL on Sep 17, 2025, price target set at 47. Investors following the Buy call captured upside momentum, with shares now at 44.3.

AMRN

Jun 25, 2025

Target

$12.00

Current

$13.80

Performance

-14.76%

On Jun 25, 2025, AMRN was evaluated by Paul Choi, who gave a Sell rating and target of 12. The recommendation was proven wrong by upward action toward 12.

PHAT

Mar 10, 2025

Target

$12.00

Current

$17.53

Performance

298.41%

Paul Choi rated PHAT as Neutral on Mar 10, 2025, setting a price target of 12. Despite the Hold call, shares climbed 298.41% to 17.53, revealing unexpected momentum.

ASND

Feb 13, 2025

Target

$225.00

Current

$199.99

Performance

40.35%

On Feb 13, 2025, ASND was given a Buy rating by Paul Choi, with a target price of 225. The stock rallied 40.35% after the rating, narrowing the gap to the target of 225 and validating the bullish stance.

RGNX

Feb 11, 2025

Target

$14.00

Current

$14.59

Performance

99.05%

RGNX received a Neutral rating from Paul Choi on Feb 11, 2025, aiming for 14. Investors saw gains of 99.05% that the cautious stance didn’t fully capture.

DVAX

Feb 11, 2025

Target

$12.00

Current

$10.86

Performance

-14.49%

On Feb 11, 2025, Paul Choi published a Sell outlook on DVAX, with a target of 12. The Sell recommendation underestimated bullish momentum toward 12.

ESPR

Dec 18, 2024

Target

$4.00

Current

$3.93

Performance

81.94%

Paul Choi on Dec 18, 2024 assigned ESPR a Neutral rating, with a price target of 4. Shares outperformed expectations, climbing 81.94% despite the neutral view.

HCM

Aug 01, 2024

Target

$19.00

Current

$13.55

Performance

-26.68%

On Aug 01, 2024, Paul Choi reaffirmed HCM with a Neutral rating, targeting 19. The Hold stance reflected market caution that was later justified.

GOSS